Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Chronic Hepatitis C
NCT00418639Phase 2Completed
- Sponsor
- Romark Laboratories
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in hepatitis C (HCV), sponsored by Romark Laboratories. Started Feb 2005; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00418639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418639.